James Scopa - Jul 20, 2023 Form 4 Insider Report for Aligos Therapeutics, Inc. (ALGS)

Role
Director
Signature
/s/ Lucinda Y. Quan, as attorney-in fact for James Scopa
Stock symbol
ALGS
Transactions as of
Jul 20, 2023
Transactions value $
$0
Form type
4
Date filed
7/21/2023, 04:11 PM
Previous filing
Jul 19, 2023
Next filing
Aug 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALGS Stock Option (Right to Buy) Award $0 +20K $0.00 20K Jul 20, 2023 Common Stock 20K $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2024 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.